Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Guaifenesin - Medication Information

Product NDC Code 71335-9616
Drug Name

Guaifenesin

Type Generic
Pharm Class Decreased Respiratory Secretion Viscosity [PE],
Expectorant [EPC],
Increased Respiratory Secretions [PE]
Active Ingredients
Guaifenesin 400 mg/1
Route ORAL
Dosage Form TABLET
RxCUI drug identifier 359601
Application Number M012
Labeler Name Bryant Ranch Prepack
Packages
Package NDC Code Description
71335-9616-1 30 tablet in 1 bottle, plastic (71335-9616-1)
71335-9616-2 20 tablet in 1 bottle, plastic (71335-9616-2)
71335-9616-3 50 tablet in 1 bottle, plastic (71335-9616-3)
71335-9616-4 60 tablet in 1 bottle, plastic (71335-9616-4)
71335-9616-5 40 tablet in 1 bottle, plastic (71335-9616-5)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredient (in each caplet) Guaifenesin 400 mg

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions do not take more than 6 doses in any 24- hour period this product is not intended for use in children under 12 years of age adults & children 12 years and over: 1 caplet every 4 hours children under 12 years: do not use

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients colloidal silicon dioxide, magnesium stearate, maltodextrin, microsrystalline cellulose, providone, stearic acid

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses helps lossen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersone mucus and make coughs more productive

Purpose

Information about the drug product’s indications for use.
Purpose Expectorant

Spl product data elements

Usually a list of ingredients in a drug product.
Guaifenesin Guaifenesin GUAIFENESIN GUAIFENESIN MICROCRYSTALLINE CELLULOSE POVIDONE, UNSPECIFIED MAGNESIUM STEARATE MALTODEXTRIN A;152

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Guaifenesin 400 mg Tablet Label

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Drug Facts Other information store at 15°-30°C (59°-86°F) Drug Facts continued on back of label TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING Distributed by: Reliable-1 Laboratoreis LLC Valley Stream, Ny 11580 www.reliable1labs.com

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments? call 516-341-0666, 8:30 am-4:30 pm ET, Monday-Friday

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious illness.

Pregnancy or breast feeding

Pregnancy or Breast feeding
If pregnant or breast-feeding, ask a health professional before use.

How supplied

Information about the available dosage forms to which the labeling applies, and for which the manufacturer or distributor is responsible. This field ordinarily includes the strength of the dosage form (in metric units), the units in which the dosage form is available for prescribing, appropriate information to facilitate identification of the dosage forms (such as shape, color, coating, scoring, and National Drug Code), and special handling and storage condition information.
HOW SUPPLIED Guaifenesin 400 mg NDC: 71335-9616-1: 30 Tablets in a BOTTLE, PLASTIC NDC: 71335-9616-2: 20 Tablets in a BOTTLE, PLASTIC NDC: 71335-9616-3: 50 Tablets in a BOTTLE, PLASTIC NDC: 71335-9616-4: 60 Tablets in a BOTTLE, PLASTIC NDC: 71335-9616-5: 40 Tablets in a BOTTLE, PLASTIC Store at 15°-30°C (59°-86°F) Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if cough lasts more then 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signes of serious illness.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API